MELLARIL-S
THIORIDAZINE
Approval overview MELLARIL-S is listed in Drugs@FDA under application 017923 (NDA).
Marketing status: Discontinued Active ingredient THIORIDAZINE Form and strength SUSPENSION;ORAL - EQ 25MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2007-12-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview MELLARIL-S is listed in Drugs@FDA under application 017923 (NDA). Marketing status: Discontinued Active ingredient THIORIDAZINE Form and strength SUSPENSION;ORAL - EQ 25MG HYDROCHLORIDE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.